Xylyx Bio Announces Exclusive License Agreement with Vanderbilt University for Donor Organ Rehabilitation Asset
Xylyx Bio, a regenerative medicine company developing innovative solutions for tissue and organ repair, today announced entry into an exclusive license agreement with Vanderbilt University for the rights to a xenogeneic cross-circulation platform that restores damaged donor...